Journal rankings · indicator year 2000
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2000
Oncology journal rankings 2000
82 ranked journals · Subfield in Medicine
Oncology has 82 ranked journals in 2000. The median journal has an OJR of 0.55, below the world average of 1.00; Q1 starts at OJR 0.95. The top three are CA A Cancer Journal for Clinicians, Nature Medicine, and Journal of Clinical Oncology.
Ranks and citation indicators: 2000. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 1997–1999, the window the 2000 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery316
- Pulmonary and Respiratory Medicine116
- Public Health, Environmental and Occupational Health113
- Cardiology and Cardiovascular Medicine100
- Oncology82
- Epidemiology77
- Infectious Diseases70
- Psychiatry and Mental health65
- Neurology62
- Radiology, Nuclear Medicine and Imaging61
- Physiology59
- Endocrinology, Diabetes and Metabolism48
Show all 42 subfields
- Orthopedics and Sports Medicine45
- Dermatology42
- Pediatrics, Perinatology and Child Health41
- Ophthalmology40
- Hematology37
- Obstetrics and Gynecology31
- Pharmacology22
- Emergency Medicine21
- Nephrology21
- Rheumatology20
- Reproductive Medicine19
- Otorhinolaryngology18
- Rehabilitation15
- Complementary and alternative medicine13
- Geriatrics and Gerontology13
- Critical Care and Intensive Care Medicine11
- Pathology and Forensic Medicine10
- Immunology and Allergy9
- Genetics8
- Anesthesiology and Pain Medicine7
- Hepatology7
- Urology5
- Gastroenterology4
- Internal Medicine3
- Transplantation2
- Family Practice1
- Anatomy0
- Biochemistry0
- Health Informatics0
- Microbiology0
82 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 1999. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 1997–1999, the window the 2000 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 1997–1999 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2000. | Compare |
|---|---|---|---|---|---|---|---|
1CA A Cancer Journal for CliniciansOAWiley · United States | 7.32Q1 | 17.62no 1999 value | 84 | 100% | $4,330 | — | |
2Nature MedicineNature Portfolio · United States | 5.12Q1 | 11.47no 1999 value | 1,357 | 10% | $12,690 | — | |
3Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 3.74Q1 | 8.28no 1999 value | 1,581 | 2% | — | — | |
4JNCI Journal of the National Cancer InstituteOxford University Press · United States | 2.98Q1 | 7.99no 1999 value | 1,004 | 17% | $5,436 | — | |
5Seminars in Cancer BiologyElsevier BV · United States | 2.71Q1 | 5.45no 1999 value | 40 | 2% | $6,060 | — | |
6Clinical Pharmacology & TherapeuticsWiley · United States | 2.05Q1 | 3.67no 1999 value | 484 | 2% | $4,410 | — | |
7CancerWiley · United States | 1.50Q1 | 2.92no 1999 value | 2,708 | 41% | $4,790 | — | |
8Cancer Causes & ControlSpringer Science+Business Media · Netherlands | 1.46Q1 | 2.49no 1999 value | 243 | 4% | $3,890 | — | |
9JNCI MonographsOxford University Press · United Kingdom | 1.45Q1 | 1.82no 1999 value | 96 | 79% | — | — | |
10British Journal of CancerSpringer Nature · United Kingdom | 1.31Q1 | 3.13no 1999 value | 2,096 | 98% | $5,190 | — | |
11JBIC Journal of Biological Inorganic ChemistrySpringer Science+Business Media · Germany | 1.28Q1 | 2.47no 1999 value | 262 | 7% | $3,990 | — | |
12Psycho-OncologyWiley · United Kingdom | 1.20Q1 | 2.31no 1999 value | 128 | 6% | $4,940 | — | |
13Annals of OncologyElsevier BV · Netherlands | 1.10Q1 | 2.33no 1999 value | 969 | 86% | $5,080 | — | |
14Hematology/Oncology Clinics of North AmericaElsevier BV · United States | 1.10Q1 | 2.57no 1999 value | 209 | 3% | $3,950 | — | |
15European Journal of CancerElsevier BV · United Kingdom | 1.10Q1 | 2.35no 1999 value | 1,192 | 5% | $4,270 | — | |
16Current Opinion in OncologyLippincott Williams & Wilkins · United Kingdom | 1.08Q1 | 2.14no 1999 value | 298 | 0% | — | — | |
17MicrocirculationWiley · United States | 1.02Q1 | 2.34no 1999 value | 90 | 1% | $3,920 | — | |
18Journal of Mammary Gland Biology and NeoplasiaSpringer Science+Business Media · United States | 1.01Q1 | 2.49no 1999 value | 107 | 0% | $4,090 | — | |
19International Journal of CancerWiley · United States | 1.00Q1 | 2.72no 1999 value | 2,845 | 45% | $5,030 | — | |
20Cancer Treatment ReviewsElsevier BV · United Kingdom | 0.97Q1 | 2.15no 1999 value | 81 | 2% | $4,910 | — | |
21Journal of Medical ScreeningSAGE Publishing · United Kingdom | 0.95Q1 | 1.51no 1999 value | 69 | 25% | $4,150 | — | |
22Cancer NursingLippincott Williams & Wilkins · United States | 0.95Q2 | 1.18no 1999 value | 172 | 0% | — | — | |
23International Journal of Colorectal DiseaseSpringer Science+Business Media · Germany | 0.89Q2 | 1.55no 1999 value | 131 | 7% | $3,790 | — | |
24Investigational New DrugsSpringer Science+Business Media · Netherlands | 0.82Q2 | 1.34no 1999 value | 130 | 0% | $4,690 | — | |
25Supportive Care in CancerSpringer Science+Business Media · Germany | 0.82Q2 | 1.59no 1999 value | 207 | 3% | $4,690 | — | |
26Diseases of the Colon & RectumLippincott Williams & Wilkins · United States | 0.81Q2 | 1.40no 1999 value | 1,105 | 0% | — | — | |
27Journal of Clinical PathologyBMJ · United Kingdom | 0.79Q2 | 1.85no 1999 value | 741 | 98% | — | — | |
28Cancer Chemotherapy and PharmacologySpringer Science+Business Media · Germany | 0.77Q2 | 1.89no 1999 value | 441 | 3% | $4,390 | — | |
29Cancer Immunology ImmunotherapyOASpringer Science+Business Media · Germany | 0.75Q2 | 2.13no 1999 value | 256 | 100% | $4,590 | — | |
30Journal of Surgical OncologyWiley · United States | 0.75Q2 | 1.43no 1999 value | 433 | 2% | $4,570 | — | |
31Journal of Cutaneous PathologyWiley · United Kingdom | 0.72Q2 | 1.34no 1999 value | 267 | 14% | $3,570 | — | |
32Critical Reviews in Oncology/HematologyElsevier BV · Netherlands | 0.70Q2 | 1.41no 1999 value | 131 | 0% | $4,190 | — | |
33OncologyKarger Publishers · Switzerland | 0.67Q2 | 1.44no 1999 value | 213 | 14% | — | — | |
34Clinical & Experimental MetastasisSpringer Science+Business Media · Netherlands | 0.67Q2 | 1.72no 1999 value | 241 | 2% | $5,090 | — | |
35Cancer InvestigationTaylor & Francis · United Kingdom | 0.64Q2 | 1.28no 1999 value | 253 | 7% | — | — | |
36Journal of Psychosocial OncologyTaylor & Francis · United States | 0.64Q2 | 0.50no 1999 value | 52 | 0% | — | — | |
37Inorganica Chimica ActaElsevier BV · Netherlands | 0.63Q2 | 1.12no 1999 value | 1,719 | 8% | $3,830 | — | |
38European Journal of EpidemiologySpringer Science+Business Media · Italy | 0.61Q2 | 1.12no 1999 value | 408 | 5% | $3,690 | — | |
39Journal of Cancer Research and Clinical OncologyOASpringer Science+Business Media · Germany | 0.60Q2 | 1.52no 1999 value | 289 | 98% | $4,390 | — | |
40American Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 0.55Q2 | 1.05no 1999 value | 427 | 3% | — | — | |
41Journal of ImmunotherapyLippincott Williams & Wilkins · United States | 0.55Q2 | 1.68no 1999 value | 323 | 0% | — | — | |
42Cancer Detection and PreventionElsevier BV · Netherlands | 0.54Q3 | 1.20no 1999 value | 129 | 0% | — | — | |
43Tumor BiologyOASAGE Publishing · Switzerland | 0.54Q3 | 1.34no 1999 value | 144 | 9% | $2,000 | — | |
44PathologyElsevier BV · United Kingdom | 0.53Q3 | 1.05no 1999 value | 276 | 3% | $3,600 | — | |
45The OncologistOAAlphaMed Press · United Kingdom | 0.50Q3 | 1.25no 1999 value | 140 | 48% | $3,852 | — | |
46Archives of Pathology & Laboratory MedicineOAAmerican Medical Association · United States | 0.49Q3 | 0.91no 1999 value | 256 | 1% | — | — | |
47Cancer PracticeWiley · United States | 0.48Q3 | 0.88no 1999 value | 77 | 1% | — | — | |
48Journal of Clinical Pharmacy and TherapeuticsWiley · United Kingdom | 0.48Q3 | 0.94no 1999 value | 144 | 44% | $2,700 | — | |
49Journal of Inorganic BiochemistryElsevier BV · United States | 0.48Q3 | 1.12no 1999 value | 388 | 8% | $4,220 | — | |
50Pathology InternationalWiley · Australia | 0.47Q3 | 0.93no 1999 value | 474 | 9% | $3,610 | — |
Subfields of Medicine, with Oncology highlighted.
- Surgery316
- Pulmonary and Respiratory Medicine116
- Public Health, Environmental and Occupational Health113
- Cardiology and Cardiovascular Medicine100
- Oncology82
- Epidemiology77
- Infectious Diseases70
- Psychiatry and Mental health65
- Neurology62
- Radiology, Nuclear Medicine and Imaging61
- Physiology59
- Endocrinology, Diabetes and Metabolism48
- Orthopedics and Sports Medicine45
- Dermatology42
- Pediatrics, Perinatology and Child Health41
- Ophthalmology40
- Hematology37
- Obstetrics and Gynecology31
- Pharmacology22
- Emergency Medicine21
- Nephrology21
- Rheumatology20
- Reproductive Medicine19
- Otorhinolaryngology18
- Rehabilitation15
- Complementary and alternative medicine13
- Geriatrics and Gerontology13
- Critical Care and Intensive Care Medicine11
- Pathology and Forensic Medicine10
- Immunology and Allergy9
- Genetics8
- Anesthesiology and Pain Medicine7
- Hepatology7
- Urology5
- Gastroenterology4
- Internal Medicine3
- Transplantation2
- Family Practice1
- Anatomy0
- Biochemistry0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2000. Corpus-wide, 66.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
28 additional Oncology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 1997–1999, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2000. Publication window: 1997–1999. How these summaries are calculated
- Ranked journals
- 82
- Window papers (baseline)
- 37,821 Change unavailable from indicator year 1997
- Median OJR
- 0.55 Change unavailable from indicator year 1997
- Rising journals (2025)
- 20
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 1997–1999 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 82 | 88 | 96 | 103 | 109 | 120 | 120 | 126 | 127 | 134 | 141 | 150 | 153 | 170 | 179 | 188 | 198 | 213 | 224 | 234 | 238 | 239 | 245 | 245 | 243 | 242 | |
| Window papers (baseline) | 37,821 | 41,430 | 44,340 | 47,392 | 49,058 | 53,111 | 57,002 | 62,106 | 66,087 | 71,283 | 77,009 | 82,075 | 86,189 | 88,804 | 93,912 | 98,660 | 102,921 | 105,891 | 109,984 | 115,044 | 121,890 | 139,666 | 156,942 | 167,602 | 163,907 | 160,807 | |
| Median OJR | 0.55 | 0.62 | 0.70 | 0.799 | 0.805 | 0.831 | 0.85 | 0.90 | 0.94 | 0.93 | 1.010 | 0.95 | 1.006 | 0.974 | 0.972 | 0.967 | 0.832 | 0.84 | 0.82 | 0.79 | 0.829 | 0.830 | 0.77 | 0.750 | 0.73 | 0.748 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.